PUBLICATIONS · 23703725
Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2013 Oct
- First author
- Malogolowkin MH
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Malogolowkin MH
- type
- Author
- name
- Krailo M
- type
- Author
- name
- Marina N
- type
- Author
- name
- Olson T
- type
- Author
- name
- Frazier AL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Malogolowkin MH
- type
- Author
- name
- Krailo M
- type
- Author
- name
- Marina N
- type
- Author
- name
- Olson T
- type
- Author
- name
- Frazier AL
- type
- Author
- bibliography ids
- nci-bib-a4abca8c96ceaafe5a4a2cbd
- book metadata
- content sha256
- d318584f2c4f3277a102222df08cd8b8f7b2eed7ebbf3ef1f9dada5fe42095db
- document type
- citation
- dois
- 10.1002/pbc.24601
- electronic publication date
- display
- 2013 May 23
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23703725
- immutable id
- pubmed:23703725@d318584f2c4f3277a102222df08cd8b8f7b2eed7ebbf3ef1f9dada5fe42095db
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 10
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 1602-5
- volume
- 60
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23703725
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- b9c5c62263934d60aba035d66fcf7224e3558a602b5fdabb4438ffc17bc9677a
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Oct
- precision
- month
- year
- 2013
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).
Preserved source evidence · Not medical advice
Triangle